In the final weeks before Romania’s presidential vote in November 2024, TikTok accounts that had previously spent years posting about manicures or fashion suddenly started promoting a little-known politician named Calin Georgescu. His posts, espousing hard-line views on immigration and anti-Semitic tropes, were viewed 120 million times before the vote. Georgescu, who had previously been polling in the single digits, stunned observers by winning the election’s first round with 23 percent of the vote.
In the Netherlands, Adriana Iamnitchi was watching closely. As chair of computational social sciences at Maastricht University, she leads the research into disinformation campaigns. She wanted to know how pro-Georgescu content was being monetized on TikTok through hidden influencer marketing and livestreamed political content.
Read full article Comments
As demand rises for specialized medications like GLP-1s, logistics companies including UPS and FedEx are adapting...
Redação FATÍVIA
·há 3 h
·2 min
Artificial intelligence may not deliver on its promise of vast economic opportunity at a price that humanity is...
Redação FATÍVIA
·há 3 h
·1 min
There's still a host of stocks with plenty of upside heading into earnings, according to Morgan Stanley. The...
Redação FATÍVIA
·há 5 h
·3 min
Earlier this year, Google AI lead Jeff Dean, on a podcast, discussed a concept that, at the time, was hardly spoken...
Redação FATÍVIA
·há 5 h
·2 min
Superagers keep youthful memories but their DNA does not explain why - Date: - July 25, 2026 - Source: - University...
Redação FATÍVIA
·há 3 h
·2 min
A single dose reversed autism-like symptoms in adult mice within hours A drug briefly reversed autism-like brain and...
Redação FATÍVIA
·há 3 h
·2 min
Oral GLP-1 drugs may quiet the brain’s food craving circuit Oral relatives of Ozempic and other semaglutide drugs...
Redação FATÍVIA
·há 3 h
·2 min
A daily fiber supplement reduced knee arthritis pain and improved strength - Date: - July 25, 2026 - Source: -...
Redação FATÍVIA
·há 3 h
·2 min
Comentários (0)
Entre ou cadastre-se para comentar.